Eli Lilly and Company v Human Genome Sciences Inc.

Core Citations

CONSIDERS

• InterDigital Technology Corporation v Nokia Corporation (Multiple Hearings)
• Medimmune Ltd v Novartis Pharmaceuticals UK Ltd and Another
• Messier Dowty Ltd v Sabena SA

CONSIDERS

• Patents Act 1977 - Articles : S-74

CONSIDERED in

• Teva Pharma BV and Another v Amgen, Inc. and Another
• Actavis Group Ptc EHF and Another v Sanofi Sanofi Pharma Bristol-Myers Squibb SNC (Claimant by Counterclaim)

REFERRED in

• Actavis Group PTC EHF v Sanofi
• Nicoventures Trading Ltd v Philip Morris Products, SA (a company formed under the laws of Switzerland)

CITED in

• VIIV Healthcare UK Ltd v Teva UK Ltd
• Eli Lilly and Company v Human Genome Sciences Inc.

This document cites

• Arrow Generics Ltd v Merck & Company Inc.
• Messier Dowty Ltd v Sabena SA
• Medimmune Ltd v Novartis Pharmaceuticals UK Ltd and Another
• InterDigital Technology Corporation v Nokia Corporation (Multiple Hearings)
• InterDigital Technology Corporation v Nokia Corporation (Multiple Hearings)



See all quotations

• Patents Act 1977
• Civil Procedure Rules 1998
• Biogen Inc. contra Smithkline Beecham Biologicals SA.
• Medeva BV v Comptroller General of Patents, Designs and Trade Marks.
• Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products
• Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
• Directive 2001/82/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to veterinary medicinal products